BackInnovation1 Biotech Overview

Innovation1 Biotech Profit Margin

Innovation1 Biotech (IVBT) has a profit margin of -5051.74%, below the sector sector average of 13.2%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Feb 2024

Annual Profit Margin (TTM)

-5051.74%

Trailing 12 months ending Feb 2024

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Innovation1 Biotech (IVBT) FAQ

The latest profit margin for IVBT is -5051.74% as of February 2024. That is below the sector sector average of 13.2%. Investors often review this figure alongside Innovation1 Biotech's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, IVBT currently prints -5051.74% for profit margin, while the sector average sits near 13.2%. That is roughly 38374.0% below the sector mean. Large gaps often invite a closer look at Innovation1 Biotech's growth, margins, and balance sheet.

Profit Margin shows how effectively Innovation1 Biotech converts resources into returns. At -5051.74%, IVBT may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IVBT's profit margin (-5051.74%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.